Intermediates for BioPharma
The new department "Intermediates for BioPharma" introduces itself and reports on the first event participations this year.
With the realignment of the Intermediates division and the establishment of the "Intermediates for BioPharma" department, Midas Pharma is responding to the steadily growing relevance of its activities in the biopharma sector.
This autumn the department participated for the first time in BIO Europe in Leipzig and TIDES Europe in Vienna. It was a great opportunity to finally meet in person with other experts in the industry and to present the current activities and strengths in BioPharma.
The focus is on building blocks for (antibody)-drug conjugates ((A)DCs) and nucleic acid therapeutics. Combined with Midas' expertise in regulatory and quality requirements (see our flyer below for more information), the Intermediates team supports its customers with tailor-made complete solutions.
Participation in the events led to interesting projects and the seminars attended provided the team with scientific information and new insights into market needs to further refine Midas' added value in the BioPharma sector.
Dr. Danielle Leone-Stumpf
Senior Director Intermediates for Pharma & BioPharma